General Information of the Compound
| Compound ID |
CP0400250
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[4-[4-(3,5-ditert-butylphenyl)piperazin-1-yl]butyl]imidazo[1,2-a]pyridine-2-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H43N5O
|
||||||||||||||||||
| Molecular Weight |
489.708
|
||||||||||||||||||
| Canonical SMILES |
CC(C)(C)c1cc(cc(c1)C(C)(C)C)N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H43N5O/c1-29(2,3)23-19-24(30(4,5)6)21-25(20-23)34-17-15-33(16-18-34)13-10-8-12-31-28(36)26-22-35-14-9-7-11-27(35)32-26/h7,9,11,14,19-22H,8,10,12-13,15-18H2,1-6H3,(H,31,36)
Show/Hide
|
||||||||||||||||||
| InChIKey |
QZCUWLCSQMYXFR-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor